Bas de Laat

General Director
Synapse Research Institute
Maastricht, Limburg, Netherlands

Presentation(s):

• PB0198 - A novel plasminogen activator anti-fibrin-uPA increases the sensitivity of the plasmin generation assay to regulators of fibrinolysis

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0132 - Determination and verification of reference intervals on the new Stago coagulation analyzer sthemO 301

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0101 - Evaluation of the new Stago system sthemO Anti-Xa M on sthemO 301 analyzer for monitoring heparin therapy.

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0038 - Low thrombin inactivation capacity is associated with an increased risk of recurrent cardiovascular events in young patients with ischemic stroke

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0345 - The novel variable heavy chain antibody Syn-VWFA1 inhibits platelet von Willebrand factor interaction in solution

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• OC 22.3 - Prothrombin Fragment 2: A Potential Therapeutic Target to Inhibit Antiprothrombin-induced Platelet Activation

  Sunday, June 23, 2024
  15:15 – 15:30 ICT

• OC 47.1 - Evaluation of plasmin generation in severe haemophilia A patients treated with novel therapies

  Monday, June 24, 2024
  14:45 – 15:00 ICT

• PB1411 - Altered whole blood thrombin generation and hyperresponsive platelets associate with thromboembolic events in patients with pancreatic ductal adenocarcinoma

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT